Lateral Flow Method
Nasal Swab Test for selftesting use – Temporary special approval after §11 MPG in Germany (BfArM GZ: 5640-S-179/21)
Please read the instructions for use carefully before performing the selftest. Please watch before using the selftest the explanatory film on http://en.wondfo.com.cn/resource/index.html.
The 2019-nCoV Antigen Test (Lateral Flow Method) is an immunochromatographic assay for rapid, qualitative detection of novel coronaviruses (2019-nCoV) antigen extracted from the nasal swab specimen. The test is to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by 2019-nCoV. The test provides preliminary test results. Negative results cannot exclude 2019-nCoV infection and they cannot be used as the sole basis for treatment or other management decision.For in vitro diagnostic use only. Under the temporary special approval after §11 MPG in Germany (BfArM GZ: 5640-S-179/21) it may be used by laypersons for selftesting. Suitable for ages from 18 years. However, for the users age under 18, it is recommended to perform the test under adult supervision, while the users age over 70 should be aware of the removal of their nasal swab or have nasal swabs assist.
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious
disease. People are generally susceptible. Currently, the patients infected by the novel corona- virus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
PRINCIPLE
The 2019-nCoV Antigen Test (Lateral Flow Method) is based on the principle of Imm nochromatography sandwich for determination of 2019-nCoV Nucleocapsid antigen extract-ed from the nasal swab specimen. When the extracted specimen is added into the test device, the specimen is absorbed into the device by capillary action, reacts with the 2019-nCoV antibody-dye conjugate and flows across the pre-coated membrane. The test Region (T) of this device is coated with antibody against Nucleocapsid protein of 2019-nCoV, while the AuNPs are modified by another antibody against Nucleocapsid protein of 2019-nCoV, and the conjugate spread on the pad. When the 2019-nCoV antigen level in the specimen is at or above the target cutoff (the detection limit of the test), the antigen bound to the antibody- AuNPs conjugate are combined by 2019-nCoV antibody immobilized in the Test Region (T) of the device, and this produces a colored test band that indicates a positive result. When the 2019-nCoV antigen level in the specimen is zero or below the target cutoff, there is not a visible colored band in the Test Region (T) of the device. This indicates a negative result.
The control Region (C) of this device is coated with goat-anti-mouse antibody, to serve as a
procedure control, a colored line will appear at the Control Region (C), if the test has been
performed properly.
Materials Required but Not Provided
Bring the test components to room temperature (15 to 30 ° C).
For this test, choose a location where you can do the test for 20 minutes as undisturbed as possible can perform.
Wash or disinfect your hands before performing the testing process.
The test can be performed with a nasal swab sample.
If possible, blow your nose before use. This can reduce the reliability of the Increase tests.
TEST PROCEDURE – I ( with Extraction Buffer Tube) For W634P0020/W634P0021/W634P0022/W634P0023
1. Nasal swab specimen extraction
(a) Transfer all of the extraction solution into the sample tube.
(b) Insert the padded nasal swab tip, moistened with nasal secretion, into the sample tube and twist the nasal swab tip against the bottom and sides of the sample tube ten times to loosen the secretion from the nasal swab tip. Place the sample tube in the sample tube holder and let the swab stand in the extraction solution for 1 minute.
(c) Take the sample tube again in one hand and squeeze it together. With the sample tube squeezed, slowly pull the nasal swab out to extract as much of the liquid as possible from the tip of the nasal swab.
(d) Place the dropper tip on the sample tube.
2. Test procedure
(e) Tear open the sealed pouch at the incision, remove the test cassette and place it on a flat surface.
(f) Turn the sample tube upside down, hold it vertically and give 3, maximum 4
Drop into the small, round, white sample well without any inscription. Start the timer.
The result window (C T) now turns purple and a line is formed on the C line and, if necessary, a second line on the T line.
(g) Even if a first line usually appears after approx. 3 minutes, please wait 15 minutes after point (f) and only then read off the test result. This result is valid. After a further 5 minutes (more than 20 minutes after point (f), the result may change again in rare cases. The result counts 15-20 minutes after point (f).
TEST PROCEDURE – II with Pre-installed Extraction Buffer) For W634P0024/W634P0025/W634P0026/W634P0027
1. Nasal swab specimen extraction
(a) Unscrew the cover of the pre-filled sample tube.
Insert the padded nasal swab tip moistened with nasal secretion into the sample tube and twist the nasal swab tip ten times against the bottom and sides of the sample tube to loosen the secretion from the nasal swab tip.
(b) Place the nasal swab with the padded side in the sample tube. Break off the tip of the nasal swab at the first stop (notch). The padded tip of the nasal swab remains in the sample tube.
(c) Then unscrew the lid. Place the sample tube in the sample tube holder and let the swab stand in the extraction solution for 1 minute.
(d) Remove the cap from the lid.
2. Test procedure
(e) Tear open the sealed pouch at the incision, remove the test cassette and place it on a flat surface.
(f) Turn the sample tube upside down, hold it vertically and give 3, maximum 4 Drop into the small, round, white sample well without any inscription. Start the timer.
The result window (C T) now turns purple and a line is formed on the C line and, if necessary, a second line on the T line.
(g) Even if a first line usually appears after approx. 3 minutes, please wait 15 minutes after point
(f) and only then read off the test result. This result is valid. After a further 5 minutes
(more than 20 minutes after point (f), the result may change again in rare cases. The result counts 15-20 minutes after point (f).
4. The test result of the reagent is used for clinical reference only and should not be used as the only one Can be used as a basis for diagnosis and treatment.
5. The clinical management of patients should be comprehensive based on their Symptoms / signs, medical history, other laboratory tests and their responses
treatment should be considered.
6. Due to the limitations of the method of antigen test reagents used for verification
and confirmation of negative test results the use of determination methods
recommended based on nucleic acid detection or virus culture.
7. Positive test results do not rule out the possibility of co-infection with other pathogens out. A negative result of the reagent can be caused by:
A. Sensitivity and Specificity
356 clinical case samples (including symptomatic and asymptomatic cases) which include 138 confirmed as COVID-19 positive and 218 confirmed as COVID-19 negative by PCR assay, were obtained for testing, and then compared the test results between Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) and the PCR results. The results are shown below.
B. Cross-reactivity
Cross-reactivity of the Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) was evaluated using specimens containing the antigens listed below. The results showed no cross-reactivity with the following:
C. Hook effect
Within the titer range of clinically positive samples of 2019-nCoV antigens, there is no hook effect in the test results of this product
D. Interference
The test result of Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) do not be interfered with the following substance:
It is not known whether other drugs will affect the test result.
If you have any questions, please contact your doctor or pharmacist and read the information leaflet that came with your medication before using the test.
Other possible risks of this test:
E. Precision
F. Limit of Detection
The LoD of this test is 1.1×10² TCID50/mL
Chen H , Wurm T , Britton P , et al. Interaction of the Coronavirus Nucleoprotein with Nucleolar Antigens and the Host Cell[J]. Journal of Virology, 2002, 76(10).
Guangzhou Wondfo Biotech Co., Ltd. No. 8 Lizhishan Road, Science City, Luogang District, 510663 Guangzhou, P.R.China
Tel: (+86) 400-830-8768
Website: www.wondfo.com.cn
E-mail: [email protected]
Test for selftesting use – Temporary special approval after §11 MPG in Germany (BfArM GZ: 5640-S-179/21)
]]>